A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

NCT05234437 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Insufficient Patient Recruitment Rates

Conditions

Interventions

Sponsor

QBiotics Group Limited